AstraZeneca
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · United Kingdom · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Biomedical Campus, 1 Francis Crick Avenu...Phone Number
+442037495000Website
www.astrazeneca.comRevenue
$61.4 BillionStock Symbol
AZNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
4
4
3
2
1
About AstraZeneca
AstraZeneca PLC is a global, science-led biopharmaceutical company focused on the discovery, development and commercialisation of prescription medicines. Its portfolio spans oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, infectious diseases and rare diseases. The company invests heavily in research and development to develop innovative medicines and improve patient outcomes, with operations and a broad commercial presence worldwide.Explore more
AstraZeneca Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AstraZeneca your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if AstraZeneca had a recent Job posting/layoffs
Check if AstraZeneca has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when AstraZeneca launches new products
Earning: See what the market has to say on AstraZeneca recently announced quarterly report
Funding: Get notified immidiatlly once AstraZeneca has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at AstraZeneca
AstraZeneca, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if AstraZeneca is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Explore company insights
Get a deeper look into AstraZeneca's structure, leadership, and market position:
Company Profile Activity
Activity Insights
AstraZeneca is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AstraZeneca is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AstraZeneca.
AstraZeneca financials insights
Gather financial insights about AstraZeneca, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$1B
2021
Other Financing Round
$168M
2024
Unspecified
$3.5B
AstraZeneca Tech Stack
A closer look at the technologies used by AstraZeneca
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
AstraZeneca News & Media
AstraZeneca (AZN)’s Lung Drug Delivers the Good News its Pipeline Needed
On September 8, 2026, CNBC reported that AstraZeneca PLC (NYSE:AZN) released full results from two successful late-stage trials of tozorakimab, an experimental drug for chronic obstructive pulmonary disease. It shows the treatment reduced moderate and severe flare-ups by roughly 30% across a broad patient population, reinforcing the company’s forecast that the drug could generate more […]AstraZeneca's news flow next year could sustain drugs group beyond 2030, says leading bank
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) offers the richest run of drug news in the pharmaceuticals sector over the next 18 months, according to JP Morgan, which sees the coming wave of trial results as key to the company's growth well into the next decade. The broker, which rates the FTSE 100...Jim Cramer Says He Is Not Going to Put His Money on AstraZeneca (AZN)
Toward the end of the lightning round on September 8, when a caller inquired about AstraZeneca PLC (NYSE:AZN), Mad Money host Jim Cramer commented: Alright, now, AstraZeneca reminds me of a company, it’s not unlike Novartis. I’m a little nervous about it. It’s been missing some of its trials. I don’t think COPD is enough […]Could AstraZeneca (AZN)’s Stronger Growth Make it a Better Bet than Amgen (AMGN)?
On August 27, AstraZeneca PLC (NYSE:AZN) and Amgen Inc. (NASDAQ:AMGN) scored a shared clinical victory. Positive high-level results from the Phase III CROSSING trial showed that their co-developed severe asthma drug, TEZSPIRE, achieved statistically significant and clinically meaningful improvements across both co-primary endpoints, histologic remission and the frequency/severity of dysphagia, and all key secondary endpoints […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AstraZeneca
Sign Up For FreeTo access detailed company insights
AstraZeneca PLC is a global, science-led biopharmaceutical company focused on the discovery, development and commercialisation of prescription medicines. Its portfolio spans oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, infectious diseases and rare diseases. The company invests heavily in research and developme... Read More
